“This usual chain of decisions … has been disrupted. And without clarity and coordination, millions may not be able to have ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new vaccines will be available.

Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates.

James Brumley has positions in Coca-Cola. The Motley Fool has positions in and recommends Amazon, Equifax, MercadoLibre, ...

U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...

In terms of liquidity and interest, the mean open interest for Pfizer options trades today is 13596.29 with a total volume of 13,024.00. In the following chart, we are able to follow the development ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...

Rare cancers make up one in four cancer diagnoses in the U.S., yet many of them lack a standardized procedure of care for ...

Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a ...

The combination will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.